Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Sanofi SNYNF OTC

Other OTC • Healthcare • Drug Manufacturers - General • FR • USD

SharesGrow Score
68/100
5/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sanofi (SNYNF) — Analyst outlook / Analyst consensus target is. Based on 23 analyst ratings, the consensus is bullish — 11 Buy, 9 Hold, 3 Sell.

SNYNF Analyst Ratings

Buy
23
Ratings
11 Buy
9 Hold
3 Sell
Based on 23 analysts giving stock ratings to Sanofi in the past 3 months
Rating breakdown
Buy
11 48%
Hold
9 39%
Sell
3 13%
48%
Buy
11 analysts
39%
Hold
9 analysts
13%
Sell
3 analysts

People Also View

JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
 RHHBY
RHHBY
Roche Holding AG
$50.99
-0.08%
 AZN
AZN
AstraZeneca PLC
$201.21
-1.55%
 NVS
NVS
Novartis AG
$152.08
-0.85%
 MRK
MRK
Merck & Co., Inc.
$117.90
-1.72%
 AMGN
AMGN
Amgen Inc.
$348.22
-0.78%
 GILD
GILD
Gilead Sciences, Inc.
$139.77
-0.48%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message